These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 226396)

  • 21. Effect of endotoxin tolerance on drug hepatotoxicity: amelioration of taurolithocholate cholestasis in the perfused rat liver.
    Utili R; Adinolfi LE; Gaeta GB; Tripodi MF; Alvaro D
    Digestion; 1987; 36(2):74-80. PubMed ID: 3552808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced biliary excretion of canalicular membrane enzymes in ethynylestradiol-induced cholestasis. Effects of ursodeoxycholic acid administration.
    Arrese M; Pizarro M; Solís N; Koenig C; Accatino L
    Biochem Pharmacol; 1995 Oct; 50(8):1223-32. PubMed ID: 7488238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of alpha-asarone and a derivative on lipids, bile flow and Na+/K+-ATPase in ethinyl estradiol-induced cholestasis in the rat.
    Garduño-Siciliano L; Labarrios F; Tamariz J; Moreno MG; Chamorro G; Muriel P
    Fundam Clin Pharmacol; 2007 Feb; 21(1):81-8. PubMed ID: 17227448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholesterol in acute cholestasis induced by taurolithocholic acid. A cytochemical study in transmission and scanning electron microscopy.
    Bonvicini F; Gautier A; Gardiol D; Borel GA
    Lab Invest; 1978 Apr; 38(4):487-95. PubMed ID: 642453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters.
    Simon FR; Fortune J; Iwahashi M; Gartung C; Wolkoff A; Sutherland E
    Am J Physiol; 1996 Dec; 271(6 Pt 1):G1043-52. PubMed ID: 8997249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The interaction of rifamycin-SV with the hepatic transport and sulfation of taurolithocolic acid in rats.
    Bonazzi P; Novelli G; Galeazzi R
    Pharmacol Res Commun; 1986 Aug; 18(8):675-85. PubMed ID: 3763675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholestasis and the interactions of sulfated glyco- and taurolithocholate with calcium.
    van der Meer R; Vonk RJ; Kuipers F
    Am J Physiol; 1988 May; 254(5 Pt 1):G644-9. PubMed ID: 3364565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Taurolithocholate-induced intrahepatic cholestasis: potentiation by methyl isobutyl ketone and methyl n-butyl ketone in rats.
    Plaa GL; Ayotte P
    Toxicol Appl Pharmacol; 1985 Sep; 80(2):228-34. PubMed ID: 4024113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic transport of organic anions in taurolithocholate-induced cholestasis in rats.
    Roma MG; Penalva GL; Agüero RM; Rodríguez Garay EA
    J Hepatol; 1994 May; 20(5):603-10. PubMed ID: 8071536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enzymatic sulfation of bile salts: III. enzymatic sulfation of taurolithocholate in human and guinea pig fetuses and adults.
    Chen LJ; Thaler MM; Bolt RJ; Golbus MS
    Life Sci; 1978 May; 22(20):1817-20. PubMed ID: 672430
    [No Abstract]   [Full Text] [Related]  

  • 31. Sex differences in hepatic sulfation of taurolithocholate in the rat.
    Hammerman KJ; Chen LJ; Fernandez-Corugedo A; Earnest DL
    Gastroenterology; 1978 Dec; 75(6):1021-5. PubMed ID: 710853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Taurolithocholate-induced increase in the intrabiliary pressure generated during retrograde intrabiliary infusion of saline in rats: antagonism by taurocholate and glycocholate.
    Jansen MA; Olson JR; Fujimoto JM
    Toxicol Appl Pharmacol; 1980 Jun; 54(1):9-19. PubMed ID: 7394789
    [No Abstract]   [Full Text] [Related]  

  • 33. Alteration of bile canalicular enzymes in cholestasis. A possible cause of bile secretory failure.
    Simon FR; Arias IM
    J Clin Invest; 1973 Apr; 52(4):765-75. PubMed ID: 4266420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of taurine on the cholestatic potential of sulfated lithocholate and its conjugates.
    Belli DC; Roy CC; Fournier LA; Tuchweber B; Giguère R; Yousef IM
    Liver; 1991 Jun; 11(3):162-9. PubMed ID: 1886461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Taurolithocholic acid and chlorpromazine cholestasis in the rhesus monkey.
    Strasberg SM; Kay RM; Ilson RG; Petrunka CN; Paloheimo JE
    Can J Physiol Pharmacol; 1979 Oct; 57(10):1138-47. PubMed ID: 116762
    [No Abstract]   [Full Text] [Related]  

  • 36. Stimulation of hepatic sodium and potassium-activated adenosine triphosphatase activity by phenobarbital. Its possible role in regulation of bile flow.
    Simon FR; Sutherland E; Accatino L
    J Clin Invest; 1977 May; 59(5):849-61. PubMed ID: 192764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monohydroxy bile salt sulfates: tauro-3 beta-hydroxy-5-cholenoate-3-sulfate induces intrahepatic cholestasis in rats.
    Mathis U; Karlaganis G; Preisig R
    Gastroenterology; 1983 Sep; 85(3):674-81. PubMed ID: 6873614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preventive effect of silymarin against taurolithocholate-induced cholestasis in the rat.
    Crocenzi FA; Sánchez Pozzi EJ; Pellegrino JM; Rodríguez Garay EA; Mottino AD; Roma MG
    Biochem Pharmacol; 2003 Jul; 66(2):355-64. PubMed ID: 12826278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of chlorpromazine on Na+-K+-ATPase pumping and solute transport in rat hepatocytes.
    Van Dyke RW; Scharschmidt BF
    Am J Physiol; 1987 Nov; 253(5 Pt 1):G613-21. PubMed ID: 2446505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The respective roles of membrane cholesterol and of sodium potassium adenosine triphosphatase in the pathogenesis of lithocholate-induced cholestasis.
    Kakis G; Phillips MJ; Yousef IM
    Lab Invest; 1980 Jul; 43(1):73-81. PubMed ID: 6248686
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.